Treatment of Neuroleptic Induced Acute Akathisia With Trazodone

• Status: Completed
• Trial end date: 2003-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Administration of trazodone for the treatment of neuroleptic induced acute akathisia in a cross-over fashion of 6 days duration. 3 days of placebo and 3 days of trazodone.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: BeerYaakov Mental Health Center
• Treatments: Trazodone

Criteria

Inclusion Criteria:

• Patients with akathisia according to DSM-IV criteria at least mild akathisia.

Exclusion Criteria:

• Change of pharmacologic regimen 7 days prior to study entry

• Significant systemic disease

• The presence of chronic akathisia

• Patients unable to cooperate